
FDA panel says no to over-the-counter allergy drug singulair
(HealthDay)—A panel of expert advisors to the U.S. Food and Drug Administration on Friday voted overwhelmingly against moving the allergy drug Singulair from prescription to over-the-counter status.
May 5, 2014
0
0